ResMed (RMD): are the analysts right?

Jun 22, 26

▲ Overweight · 🎯$266

Price at call : $188.45 — upside +41%

Today : $219.75 — upside +21%

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

in progress (365j)
matures : Jun 22, 27

Morgan Stanley ↗

Jun 17, 26

■ Equal-Weight neutral · not a buy · 🎯$230

Price at call : $186.29 — gap to target +23%

Today : $219.75 — gap to target +5%

🎯 on RMD : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)

in progress (365j)
matures : Jun 17, 27

Jun 15, 26

▲ Buy · 🎯$270

Price at call : $193.94 — upside +39%

Today : $219.75 — upside +23%

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)

in progress (365j)
matures : Jun 15, 27

May 1, 26

▲ Outperform · 🎯$321

Price at call : $209.43 — upside +53%

Today : $219.75 — upside +46%

🎯 on RMD : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)

in progress (365j)
matures : May 1, 27

Wells Fargo ↗

May 1, 26

■ Equal-Weight neutral · not a buy · 🎯$227

Price at call : $209.43 — gap to target +8%

Today : $219.75 — gap to target +3%

🎯 on RMD : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)

in progress (365j)
matures : May 1, 27

Apr 27, 26

▲ Overweight · 🎯$290

Price at call : $217.14 — upside +34%

Today : $219.75 — upside +32%

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

in progress (365j)
matures : Apr 27, 27

Apr 9, 26

▲ Buy · 🎯$340

Price at call : $228.87 — upside +49%

Today : $219.75 — upside +55%

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)

in progress (365j)
matures : Apr 9, 27

Feb 2, 26

▲ Buy · 🎯$345

Price at call : $251.41 — upside +37%

Today : $219.75 — upside +57%

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)

in progress (365j)
matures : Feb 2, 27

Jan 30, 26

▲ Outperform · 🎯$314

Price at call : $254.74 — upside +23%

Today : $219.75 — upside +43%

🎯 on RMD : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)

in progress (365j)
matures : Jan 30, 27

Jan 30, 26

■ Neutral neutral · not a buy · 🎯$275

Price at call : $254.74 — gap to target +8%

Today : $219.75 — gap to target +25%

🎯 on RMD : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)

in progress (365j)
matures : Jan 30, 27

Wells Fargo ↗

Jan 30, 26

■ Equal-Weight neutral · not a buy · 🎯$270

Price at call : $254.74 — gap to target +6%

Today : $219.75 — gap to target +23%

🎯 on RMD : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)

in progress (365j)
matures : Jan 30, 27

Jan 30, 26

■ Hold neutral · not a buy · 🎯$265

Price at call : $254.74 — gap to target +4%

Today : $219.75 — gap to target +21%

🎯 on RMD : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)

in progress (365j)
matures : Jan 30, 27

Dec 18, 25

■ Hold neutral · not a buy · 🎯$260

Price at call : $242.55 — gap to target +7%

Today : $219.75 — gap to target +18%

🎯 on RMD : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)

in progress (365j)
matures : Dec 18, 26

Baird ↗

Dec 16, 25

■ Neutral neutral · not a buy · 🎯$275

Price at call : $247.34 — gap to target +11%

Today : $219.75 — gap to target +25%

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 52.3% · +7.1% (287 calls)

in progress (365j)
matures : Dec 16, 26

Baird ↗

Nov 3, 25

▲ Outperform · 🎯$300

Price at call : $248.95 — upside +21%

Today : $219.75 — upside +37%

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 52.3% · +7.1% (287 calls)

in progress (365j)
matures : Nov 3, 26

Oct 31, 25

▲ Outperform · 🎯$303

Price at call : $248.95 — upside +22%

Today : $219.75 — upside +38%

🎯 on RMD : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)

in progress (365j)
matures : Oct 31, 26

Oct 31, 25

▲ Overweight · 🎯$299

Price at call : $246.88 — upside +21%

Today : $219.75 — upside +36%

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

in progress (365j)
matures : Oct 31, 26

Mizuho ↗

Oct 31, 25

▲ Outperform · 🎯$300

Price at call : $246.88 — upside +22%

Today : $219.75 — upside +37%

🎯 on RMD : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)

in progress (365j)
matures : Oct 31, 26

Morgan Stanley ↗

Oct 21, 25

▲ Overweight · 🎯$304

Price at call : $268.22 — upside +13%

Today : $219.75 — upside +38%

🎯 on RMD : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)

in progress (365j)
matures : Oct 21, 26

Wells Fargo ↗

Oct 13, 25

■ Equal-Weight neutral · not a buy · 🎯$280

Price at call : $273.01 — gap to target +3%

Today : $219.75 — gap to target +27%

🎯 on RMD : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)

in progress (365j)
matures : Oct 13, 26

Sep 18, 25

▲ Buy · 🎯$330

Price at call : $273.29 — upside +21%

Today : $219.75 — upside +50%

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)

in progress (365j)
matures : Sep 18, 26

Mizuho ↗

Aug 1, 25

▲ Outperform · 🎯$290

Price at call : $291.44 — upside -0%

Today : $219.75 — upside +32%

🎯 on RMD : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)

in progress (365j)
matures : Aug 1, 26

Aug 1, 25

■ Hold neutral · not a buy · 🎯$270

Price at call : $291.44 — gap to target -7%

Today : $219.75 — gap to target +23%

🎯 on RMD : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)

in progress (365j)
matures : Aug 1, 26

Aug 1, 25

▲ Outperform · 🎯$300

Price at call : $291.44 — upside +3%

Today : $219.75 — upside +37%

🎯 on RMD : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)

in progress (365j)
matures : Aug 1, 26

UBS ↗

Aug 1, 25

▲ Buy · 🎯$325

Price at call : $291.44 — upside +12%

Today : $219.75 — upside +48%

🎯 on RMD : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)

in progress (365j)
matures : Aug 1, 26

Aug 1, 25

▲ Overweight · 🎯$298

Price at call : $279.2 — upside +7%

Today : $219.75 — upside +36%

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

in progress (365j)
matures : Aug 1, 26

Aug 1, 25

■ Neutral neutral · not a buy · 🎯$270

Price at call : $279.2 — gap to target -3%

Today : $219.75 — gap to target +23%

🎯 on RMD : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)

in progress (365j)
matures : Aug 1, 26

Jul 16, 25

▲ Outperform · 🎯$294

Price at call : $256.42 — upside +15%

Today : $219.75 — upside +34%

🎯 on RMD : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)

in progress (365j)
matures : Jul 16, 26

Mizuho ↗

Jul 16, 25

▲ Outperform · 🎯$270

Price at call : $254.25 — upside +6%

Today : $219.75 — upside +23%

🎯 on RMD : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)

in progress (365j)
matures : Jul 16, 26

Apr 24, 25

■ Sector Perform neutral · not a buy · 🎯$255

Price at call : $235.88 — gap to target +8%

Today : $219.75 — gap to target +16%

🎯 on RMD : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)

in progress (365j)
matures : Apr 24, 26

UBS ↗

Apr 24, 25

▲ Buy · 🎯$285

Price at call : $235.88 — upside +21%

Today : $219.75 — upside +30%

Expected +21% · Actual -6% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 0% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)

-5.9%

stock -6% · XLV +4%

JP Morgan ↗

Apr 24, 25

▲ Overweight · 🎯$290

Price at call : $235.88 — upside +23%

Today : $219.75 — upside +32%

Expected +23% · Actual -6% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)

-5.9%

stock -6% · XLV +4%

Apr 24, 25

■ Neutral neutral · not a buy · 🎯$248

Price at call : $235.88 — gap to target +5%

Today : $219.75 — gap to target +13%

🎯 on RMD : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)

in progress (365j)
matures : Apr 24, 26

Apr 24, 25

▲ Overweight · 🎯$274

Price at call : $235.88 — upside +16%

Today : $219.75 — upside +25%

Expected +16% · Actual -6% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

-5.9%

stock -6% · XLV +4%

Apr 21, 25

▲ Overweight · 🎯$269

Price at call : $214.08 — upside +26%

Today : $219.75 — upside +22%

Expected +26% · Actual +4% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

+3.7%

stock +4% · XLV +8%

Mar 5, 25

▲ Buy

Actual +12% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)

+12.4%

stock +12% · XLV +2%

Mar 5, 25

■ Hold neutral · not a buy · 🎯$240

Price at call : $225.03 — gap to target +7%

Today : $219.75 — gap to target +9%

🎯 on RMD : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)

in progress (365j)
matures : Mar 5, 26

JP Morgan ↗

Jan 31, 25

▲ Overweight · 🎯$286

Price at call : $240.55 — upside +19%

Today : $219.75 — upside +30%

Expected +19% · Actual +6% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 50% (2 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)

+5.9%

stock +6% · XLV +6%

Jan 31, 25

▲ Overweight · 🎯$280

Price at call : $240.55 — upside +16%

Today : $219.75 — upside +27%

Expected +16% · Actual +6% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

+5.9%

stock +6% · XLV +6%

Jan 31, 25

■ Neutral neutral · not a buy · 🎯$260

Price at call : $240.55 — gap to target +8%

Today : $219.75 — gap to target +18%

🎯 on RMD : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)

in progress (365j)
matures : Jan 31, 26

Needham ↗

Jan 31, 25

■ Hold neutral · not a buy

🎯 on RMD : no call matured yet · 📊 on Health : 51% · +4.4% (153 calls)

in progress (365j)
matures : Jan 31, 26

Jan 10, 25

■ Neutral neutral · not a buy · 🎯$252

Price at call : $233.82 — gap to target +8%

Today : $219.75 — gap to target +15%

🎯 on RMD : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)

in progress (365j)
matures : Jan 10, 26

Dec 13, 24

■ Hold neutral · not a buy · 🎯$250

Price at call : $238.52 — gap to target +5%

Today : $219.75 — gap to target +14%

🎯 on RMD : no call matured yet · 📊 on Health : 51.2% · +8.2% (297 calls)

in progress (365j)
matures : Dec 13, 25

Oct 25, 24

■ Sector Perform neutral · not a buy · 🎯$232

Price at call : $246.83 — gap to target -6%

Today : $219.75 — gap to target +6%

🎯 on RMD : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)

in progress (365j)
matures : Oct 25, 25

Oct 25, 24

▲ Overweight · 🎯$266

Price at call : $246.83 — upside +8%

Today : $219.75 — upside +21%

Expected +8% · Actual +5% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 75% (4 calls matureds) · 📊 on Health : 44.6% · -1.1% (139 calls)

+5.0%

stock +5% · XLV -2%

Baird ↗

Oct 25, 24

▲ Outperform · 🎯$283

Price at call : $256.07 — upside +11%

Today : $219.75 — upside +29%

Expected +11% · Actual +1% · Reason (≥ +15%) : ✗ No

🎯 on RMD : 100% (1 call matured) · 📊 on Health : 52.3% · +7.1% (287 calls)

+1.2%

stock +1% · XLV -1%

Needham ↗

Oct 25, 24

■ Hold neutral · not a buy

🎯 on RMD : no call matured yet · 📊 on Health : 51% · +4.4% (153 calls)

in progress (365j)
matures : Oct 25, 25